CEU COURSE: Massive Transfusion Protocols: Current Practices and New Innovations for Managing Traumatic Hemorrhage

Massive transfusion practices have changed considerably in the last several years from primarily laboratory-guided therapy to formula-driven protocols. In this program, the rationale for developing massive transfusion protocols will be reviewed. The evidence in the literature supporting and refuting the use of high ratios of plasma to red blood cells will also be discussed. Lastly, new ideas and products that should be considered for use in a massive transfusion protocol will be described. There are no participant prerequisites for this activity. The result of the PROPPR study was published in JAMA in 2015 (JAMA 2015; 313(5): 471-482). There were no significant differences in the primary outcomes of 24-hour and 30-day all-cause mortality between the 1:1:1 group and the 1:1:2 group. Death due to exsanguination was decreased in the 1:1:1 group and more patients in that group achieved hemostasis. No other safety differences between the two groups was noted.

TARGET AUDIENCE: Technologists, technicians and laboratory managers. 

 

Enter Course

LEARNING OBJECTIVES
At the conclusion of this course, participants should be able to:

  1. Define a Massive Transfusion and describe the important elements required in creating a massive transfusion protocol (MTP).
  2. Discuss the proven and controversial aspects of blood product ratios in formula-driven MTPs. Describe the advantages and challenges in using Group A plasma for trauma resuscitation.
  3. Identify 'new' blood products such as whole blood and cold-stored platelets that may be beneficial for use in trauma resuscitation.

LEARNING TASKS
To receive CEU credit for this course, participants must:
 

  1. Review the presentation "Massive Transfusion Protocols: The Rationale for Ratios and the Impact on Patients" or read the PowerPoint slides and accompanying notes available as a printable Adobe Reader® file.
  2. Take the online Post-Test.
  3. Complete the online Course Evaluation.
  4. Print the certificate awarding 1.0 CEU SUCCESS CEU Credit through the SUCCESSTM program.

FACULTY
P. Dayand Borge MD, PhD
Divisional Chief Medical Officer, American Red Cross Blood Services
East Division
Baltimore, MD

ACTIVITY PLANNER
Liz Marcus
Director, Hospital Sales and Marketing
Biomedical Headquarters American Red Cross
Washington DC

DISCLOSURES
The faculty has indicated that he has no relevant financial relationships with commercial interests to disclose. The presenter has indicated that he has a research grant with Fenwal Corporation.  No commercial support was received for this activity.

DISCLAIMER
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the American Red Cross Biomedical Services. Information herein is presented for educational purposes only.

PASSING REQUIREMENTS
If you correctly answer 70% or more of the post-test items you may claim credit.

DISCLOSURE STATEMENT
All faculty participating in ARCBS continuing education programs are expected to disclose to learners whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s); faculty are also expected to disclose off-label and/or investigational uses of products under discussion.


RELEASE DATE: 11/30/2018

CME CREDITS: 1.0 SUCCESS Credit(s)TM

EXPIRATION DATE: 11/30/2020

ESTIMATED TIME TO COMPLETE ACTIVITY:
1.0 hour
Last modified: Thursday, November 29, 2018, 01:36 PM